StonvexLoading…
StonvexStonvexStonvexCore line items from ACVA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2022 2022-12-31 |
|---|---|
Revenue | $3.80M |
Operating Income | $-106.21M |
Net Income | $-102.19M |
EPS (Diluted) | $-0.65 |
Total Assets | $914.92M |
Total Liabilities | $429.20M |
Cash & Equivalents | $280.75M |
Free Cash Flow OCF − CapEx | $-78.39M |
Shares Outstanding | 156.99M |